Supplementary Methods, Legends from Nuclear–Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis

MLA

Michael W. Deininger, et al. Supplementary Methods, Legends from Nuclear–Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6e38d86a4e9a280d75b2d3ca316c4b4f&authtype=sso&custid=ns315887.

APA

Michael W. Deininger, Thomas O’Hare, Josef T. Prchal, Kenneth M. Boucher, Rodney R. Miles, Mohamed E. Salama, Todd W. Kelley, Jamshid S. Khorashad, Sharon Shacham, Erkan Baloglu, Brayden J. Halverson, Sabina I. Swierczek, Hannah M. Redwine, Kevin C. Gantz, Phillip M. Clair, Anna M. Eiring, William L. Heaton, Ami B. Patel, Hein Than, … Dongqing Yan. (2023). Supplementary Methods, Legends from Nuclear–Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis.

Chicago

Michael W. Deininger, Thomas O’Hare, Josef T. Prchal, Kenneth M. Boucher, Rodney R. Miles, Mohamed E. Salama, Todd W. Kelley, et al. 2023. “Supplementary Methods, Legends from Nuclear–Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6e38d86a4e9a280d75b2d3ca316c4b4f&authtype=sso&custid=ns315887.